JP Stock MarketDetailed Quotes
4564 OncoTherapy Science
- 33
- +1+3.13%
20min DelayNot Open Nov 25 15:30 JST
8.96BMarket Cap-5454P/E (Static)
34High32Low6.43MVolume32Open32Pre Close212.90MTurnover6452wk High2.70%Turnover Ratio271.64MShares1552wk Low-4.81EPS TTM7.85BFloat Cap863Historical HighLossP/E (Static)237.79MShs Float15Historical Low-6.05EPS LYR6.25%Amplitude--Dividend TTM8.96P/B100Lot Size--Div YieldTTM
About OncoTherapy Science Company
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
Company Profile
Symbol4564
Company NameOncoTherapy Science
Founded2001-04-06
MarketTSE Growth
Employees54
Fiscal Year Ends03-31
Address11th Floor, Kanagawa Science Park R&D 3-2-1 Sakado
Zip Code210-0005
Phone044-201-6429
Websitewww.oncotherapy.co.jp
Company Executives
- Name
- Position
- Salary
- Junichi Shimada
- President and Chief Executive Officer
- --
- Paku zai Ken
- Chief Scientific Officer and Director of Management Division
- --
- Toshio Kato
- Chairman of the Board
- --
- Yuichi Komine
- Independent Director
- --
- Yoshio Mitsuki
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data